Impact of Drug-Eluting Stents Among Insulin-Treated Diabetic Patients

JACC: Cardiovascular Interventions - Netherlands
doi 10.1016/j.jcin.2008.02.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Role of Drug Eluting Stents in Diabetic Patients

Heart
Cardiovascular MedicineCardiology
2006English

Drug-Eluting Stents

CMAJ
Medicine
2007English

Drug-Eluting Stents

CMAJ
Medicine
2007English

Comparison of Three-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation Among Insulin-Treated Diabetic, Non–Insulin-Treated Diabetic, and Non-Diabetic Patients From J-Cypher Registry

American Journal of Cardiology
Cardiovascular MedicineCardiology
2011English

Comparison of Outcome in 1809 Patients Treated With Drug-Eluting Stents or Bare-Metal Stents in a Real-World Setting

Vascular Health and Risk Management
2011English

Bringing Reality to Drug-Eluting Stents

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Recent Advances in Drug Eluting Stents

International Journal of Pharmaceutics
Pharmaceutical Science
2013English

Downstream Coronary Effects of Drug-Eluting Stents

American Heart Journal
Cardiovascular MedicineCardiology
2011English

Bessere Prognose Durch Neue Drug-Eluting Stents?

CardioVasc
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy